CG
AMED

Cutler Group’s Amedisys AMED Stock Holding History

Cutler Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,900
Closed -$4K – 4751
2020
Q3 		$4K Buy
+1,900
New +$432K ﹤0.01% 3599
2018
Q3 		– Sell
-6,800
Closed -$22K – 4042
2018
Q2 		$22K Buy
+6,800
New +$499K ﹤0.01% 2120
2018
Q1 		– Sell
-1,500
Closed -$1K – 4360
2017
Q4 		$1K Buy
+1,500
New +$79K ﹤0.01% 4342
2017
Q2 		– Sell
-7,700
Closed -$7K – 6292
2017
Q1 		$7K Buy
+7,700
New +$367K ﹤0.01% 4353
2016
Q4 		– Sell
-1,600
Closed -$2K – 6432
2016
Q3 		$2K Buy
1,600
+1,000
+167% +$49.9K ﹤0.01% 5613
2016
Q2 		$1K Buy
+600
New +$30.3K ﹤0.01% 5951
2016
Q1 		– Sell
-6,500
Closed -$121K – 6413
2015
Q4 		$121K Buy
+6,500
New +$260K 0.01% 1599

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cutler Group's AMED Position: Q1 2017 in Review

Cutler Group sold out of Amedisys (AMED) in Q1 2017, closing a stake of 83 shares — an estimated $3.96K sold.

Cutler Group first reported a position in AMED in Q4 2015 and held it in 2 quarters. The position peaked at $804K in Q4 2015. 152 funds tracked by Wall St. Rank hold AMED as of Q1 2017.

  • Cutler Group reported no remaining Amedisys position as of Q1 2017 after selling out during the quarter.
  • Cutler Group sold 83 Amedisys shares in Q1 2017, an estimated $3.96K.
  • Cutler Group first reported a position in Amedisys in Q4 2015 and held it in 2 quarters.
  • Cutler Group's Amedisys position peaked at $804K in Q4 2015.
  • 152 funds tracked by Wall St. Rank held Amedisys as of Q1 2017.

Based on Cutler Group's 13F filing for Q1 2017, filed 11 Apr 2017.